Evidence map›Paper›PMID 40760173›Full record

ArticlePediatric research2026

Neurodevelopmental and social determinants of school support received by children born preterm.

Anna-Veera Seppänen, Véronique Pierrat, Laetitia Marchand-Martin, Marie-Laure Charkaluk, Jean-Baptiste Muller, Stéphane Marret, Jennifer Zeitlin, Mariane Sentenac

Abstract read
In one paragraph

Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anna-Veera SeppänenUniversité Paris Cité, INSERM UMR 1153, Centre for Research in Epidemiology and Statistics (CRESS), Obstetric, Perinatal, Paediatric Life Course Epidemiology Research Team (OPPaLE), Paris, France. anna-veera.seppanen@inserm.fr.ORCID http://orcid.org/0000-0001-5615-0639
Véronique PierratUniversité Paris Cité, INSERM UMR 1153, Centre for Research in Epidemiology and Statistics (CRESS), Obstetric, Perinatal, Paediatric Life Course Epidemiology Research Team (OPPaLE), Paris, France.
Laetitia Marchand-MartinUniversité Paris Cité, INSERM UMR 1153, Centre for Research in Epidemiology and Statistics (CRESS), Obstetric, Perinatal, Paediatric Life Course Epidemiology Research Team (OPPaLE), Paris, France.
Marie-Laure CharkalukUniversité Paris Cité, INSERM UMR 1153, Centre for Research in Epidemiology and Statistics (CRESS), Obstetric, Perinatal, Paediatric Life Course Epidemiology Research Team (OPPaLE), Paris, France.
Jean-Baptiste MullerDepartment of Neonatal Medicine, Intensive Care, and Neuropediatrics, Rouen University Hospital, Normandy University, Rouen, France.
Stéphane MarretDepartment of Neonatal Medicine, Intensive Care, and Neuropediatrics, Rouen University Hospital, Normandy University, Rouen, France.
Jennifer ZeitlinUniversité Paris Cité, INSERM UMR 1153, Centre for Research in Epidemiology and Statistics (CRESS), Obstetric, Perinatal, Paediatric Life Course Epidemiology Research Team (OPPaLE), Paris, France.
Mariane SentenacUniversité Paris Cité, INSERM UMR 1153, Centre for Research in Epidemiology and Statistics (CRESS), Obstetric, Perinatal, Paediatric Life Course Epidemiology Research Team (OPPaLE), Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChildren born preterm face higher risks of neurodevelopmental difficulties that, with social vulnerabilities, may impair school performance. We described and assessed determinants of receiving school support in preterm-born children in France.

methodsWe used data from the prospective population-based cohort of births before 35 weeks' gestation in France, EPIPAGE-2, to estimate crude rates and adjusted relative risks (using multivariable, mixed-effects generalized linear models) of receiving school support at age five, by children's neurodevelopment at five, sociodemographic characteristics, and region.

resultsOut of 3,007 children, 99% attended mainstream school at age five, of whom 9% received school support. Support was more often received by boys (11%; aRR = 1.37) than girls (6%), children born at 24-27 weeks' gestation (21%; aRR = 2.78 compared to 32-34 weeks), and children with moderate or severe neurodevelopmental impairments (MSNDI: cerebral palsy, cognitive impairment, visual impairment or blindness, and/or hearing impairment or deafness) (39%; aRR = 17.25 compared to none). Receiving support was not associated with sociodemographic characteristics, after adjusting for covariates.

conclusionsNeurodevelopmental impairment is a key determinant for receiving school support. However, 9% of the cohort and under 40% of children with MSNDI were receiving support, raising questions on whether unmet needs for school support exist in France. IMPACT: This study provides an overview of school support received at age five by children born before 35 weeks' gestation in France, and associated determinants Less than 10% of the total cohort and 40% of children with a moderate or severe neurodevelopmental impairment were receiving school support Cognitive and neurodevelopmental impairments were key determinants for receiving school support, but sociodemographic characteristics were not Our results raise questions about whether unmet needs for school support exist, calling for further research on the support available in schools, decision-making processes for allocating them, and the psychosocial and academic consequences of their provision on children.

Indexed as

Child DevelopmentInfant, PrematureNeurodevelopmental DisordersSchoolsSocial Determinants of HealthChild, PreschoolFemaleFranceGestational AgeHumansInfant, NewbornMaleProspective Studies

Identifiers

PMID40760173
PMCPMC13102684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.